# Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy

> **NCT04019548** · PHASE3 · RECRUITING · sponsor: **Jules Bordet Institute** · enrollment: 110 (estimated)

## Conditions studied

- Oropharyngeal Cancer

## Interventions

- **DEVICE:** Percutaneous Endoscopic Gastrotomy tube placement
- **DRUG:** Cisplatin injection
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT04019548
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-16
- **Primary completion:** 2027-11-01
- **Final completion:** 2030-05-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04019548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04019548, "Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04019548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*